| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |